elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37694765-BED53BC3-45DB-49A7-8267-5A1023EE8EB5
Q37694765-BED53BC3-45DB-49A7-8267-5A1023EE8EB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37694765-BED53BC3-45DB-49A7-8267-5A1023EE8EB5
Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.
P2093
Q37694765-BED53BC3-45DB-49A7-8267-5A1023EE8EB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37694765-BED53BC3-45DB-49A7-8267-5A1023EE8EB5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
640ffc52b1ff0c18fa32d38052837e68c5dd5463
P1545
8
http://www.w3.org/2001/XMLSchema#string
P2093
Zhihong Niu
http://www.w3.org/2001/XMLSchema#string